Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Novel epigenetic targets

Synthetic lethality - EZH2 inhibitor tazemetostat in INI1-negative tumors

Date

05 Mar 2018

Session

Novel epigenetic targets

Presenters

Antoine Italiano

Authors

A. Italiano

Author affiliations

  • Early Phase Trials Unit, Institute Bergonié, 33076 - Bordeaux/FR
More

Resources

Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings